Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Melotte, Veerle" or (type any "bookEditor issueEditor" and editor="Melotte, Veerle")

Add to list
Analysis of DNA methylation in cancer : location revisited

Alexander Koch, Sophie C Joosten, Zheng Feng, Tim C de Ruijter, Muriel X Draht, Veerle Melotte, Kim M Smits, Jurgen Veeck, James G Herman, Leander Van Neste, et al.

(2018) NATURE REVIEWS CLINICAL ONCOLOGY. 15(7). p.459-466
Add to list
A four-gene promoter methylation marker panel consisting of GREM1, NEURL, LAD1, and NEFH predicts survival of clear cell renal cell cancer patients

Iris JH van Vlodrop, Sophie C Joosten, Tim De Meyer (UGent) , Kim M Smits, Leander Van Neste (UGent) , Veerle Melotte, Marcella MLL Baldewijns, Leo J Schouten, Piet A van den Brandt, Jana Jeschke, et al.

(2017) CLINICAL CANCER RESEARCH. 23(8). p.2006-2018
Add to list
Spectrin Repeat Containing Nuclear Envelope 1 and Forkhead Box Protein E1 are promising markers for the detection of colorectal cancer in blood

Veerle Melotte, Joo Mi Yi, Marjolein HFM Lentjes, Kim M Smits, Leander Van Neste, Hanneke EC Niessen, Kim AD Wouters, Joost Louwagie, Kornel E Schuebel, James G Herman, et al.

(2015) CANCER PREVENTION RESEARCH. 8(2). p.157-164
Add to list
- Journal Article
- A1
- open access
Emerging evidence for CHFR as a cancer biomarker : from tumor biology to precision medicine

Sarah Derks, Arjen HG Cleven, Veerle Melotte, Kim M Smits, Johann C Brandes, Nilofer Azad, Wim Van Criekinge (UGent) , Adriaan P de Bruïne, James G Herman and Manon van Engeland

(2014) CANCER AND METASTASIS REVIEWS. 33(1). p.161-171
Add to list
- Conference Paper
- C3
CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer

Manon van Engeland, Arjen Cleven, Sarah Derks, Muriel XG Draht, Kim M Smits, Veerle Melotte, Matty P Weijenberg, James Gordon Herman, Adriaan P de Bruine and Wim Van Criekinge (UGent)

(2013) JOURNAL OF CLINICAL ONCOLOGY. 31(15, suppl.).
Add to list
The CpG island methylator phenotype: what's in a name?

Laura AE Hughes, Veerle Melotte, Joachim De Schrijver (UGent) , Michiel de Maat, Vincent THBM Smit, Judith VMG Bovée, Pim J French, Piet A van den Brandt, Leo J Schouten, Tim De Meyer (UGent) , et al.

(2013) CANCER RESEARCH. 73(19). p.5858-5868
Add to list
DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT

Linda JW Bosch, Frank A Oort, Maarten Neerincx, Carolina AJ Khalid-de Bakker, Jochim S Terhaar sive Droste, Veerle Melotte, Daisy MAE Jonkers, Ad AM Masclee, Sandra Mongera, Madeleine Grooteclaes, et al.

(2012) CANCER PREVENTION RESEARCH. 5(3). p.464-472
Add to list
The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applications

Veerle Melotte, Xianghu Qu, Maté Ongenaert (UGent) , Wim Van Criekinge (UGent) , Adriaan P de Bruine, H Scott Baldwin and Manon van Engeland

(2010) FASEB JOURNAL. 24(11). p.4153-4166
Add to list
- Journal Article
- A1
GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer

Debby MEI Hellebrekers, Marjolein HFM Lentjes, Sandra M van den Bosch, Veerle Melotte, Kim AD Wouters, Kathleen LJ Daenen, Kim M Smits, Yohimitsu Akiyama, Yasuhito Yuasa, Silvia Sanduleanu, et al.

(2009) CLINICAL CANCER RESEARCH. 15(12). p.3990-3997
Add to list
GATA4 and GATA5 act as tumor suppressors and are potential biomarkers in colorectal cancer

Debby Hellebrekers, Marjolein Lentjes, Sandra van den Bosch, Kim Wouters, Kathleen Daenen, Veerle Melotte, Kim Smits, Iris Partouns-Hendriks, Yoshimitsu Akiyama, Yasuhito Yuasa, et al.

(2008) CELLULAR ONCOLOGY. 30(2). p.129-130

Academic Bibliography

Analysis of DNA methylation in cancer : location revisited

A four-gene promoter methylation marker panel consisting of GREM1, NEURL, LAD1, and NEFH predicts survival of clear cell renal cell cancer patients

Spectrin Repeat Containing Nuclear Envelope 1 and Forkhead Box Protein E1 are promising markers for the detection of colorectal cancer in blood

Emerging evidence for CHFR as a cancer biomarker : from tumor biology to precision medicine

CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer

The CpG island methylator phenotype: what's in a name?

DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT

The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applications

GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer

GATA4 and GATA5 act as tumor suppressors and are potential biomarkers in colorectal cancer

Contents

Support

Contact